Entourtabinofovir tablets contain two active ingredients: entourtabin and fuma acid nofovir difficide, both highly effective antiretroviral drugs.
entourage nofovir tablets as a single tablet, with simplified treatment, significant efficacy, high patient compliance, low drug resistance and so on, has been included in the national health insurance Class B drugs.
Truvada, the original manufacturer of Truvada, was first approved by the FDA in August 2004 for the treatment of HIV-1 infection with other antiretroviral drugs, and in 2012 was approved by the FDA for adult-obtained HIV-1 infection due to sexual transmission, the world's first HIV prevention drug.
2019, Truvada's global sales exceeded $2.8 billion, according to Gilead Financial Results.
Truvada Global Sales (in millions of U.S. dollars) Source: Minnet Multinational Listed Companies Sales Database The current domestic market Entrutha Binte Nofowe tablet approval enterprises only Gilead and Zhengda Tianqing Pharmaceutical Group, Zhengda Tianqing Pharmaceutical Group in June 2020 won the first imitation of the species;
Enqutai Bintinofove film pending approval enterprise Source: Minnet one-click search Minet data show that Hesco and Qilu Pharmaceutical's Enqutami Nofowe film listing application in the review, Anhui Baker Bio's Enqutina Bintinofowe film registration status has been changed to "in the approval", if successfully approved will become the second domestic.
source: MiNet Database, NMPA.